Also trades as: AFT.NZ (NZE) · $vol 0M
AFP.AX ASX
AFT Pharmaceuticals Limited
1W: +0.3%
1M: -8.2%
3M: +14.6%
YTD: +6.8%
1Y: +43.8%
3Y: +12.0%
5Y: +52.6%
A$3.50 ($2.43)
+0.05 (+1.45%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$257M
+24.9% ▲
5Y CAGR: +17.8%
Gross Profit
$111M
+24.9% ▲
5Y CAGR: +18.0%
Operating Income
$25M
+114.0% ▲
5Y CAGR: +18.5%
Net Income
$15M
+24.0% ▲
5Y CAGR: +13.8%
EPS (Diluted)
$0.15
+36.4% ▲
5Y CAGR: +14.8%
EBITDA
$29M
+33.6% ▲
5Y CAGR: +18.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $130M | $157M | $194M | $205M | $257M |
| YoY Growth | +15.2% | +20.2% | +23.9% | +5.9% | +24.9% |
| Cost of Revenue | $69M | $84M | $107M | $116M | $145M |
| Gross Profit | $62M | $73M | $87M | $89M | $111M |
| Gross Margin | 47.4% | 46.6% | 44.8% | 43.4% | 43.4% |
| R&D Expenses | $6M | $6M | $8M | $11M | $11M |
| SG&A Expenses | $38M | $49M | $56M | $63M | $75M |
| Operating Expenses | $41M | $53M | $67M | $77M | $86M |
| Operating Income | $20M | $20M | $20M | $12M | $25M |
| Operating Margin | 15.6% | 12.6% | 10.5% | 5.7% | 9.8% |
| Interest Expense | $2M | $3M | $4M | $3M | $3M |
| Income Before Tax | $19M | $16M | $22M | $16M | $22M |
| Tax Expense | -$1M | $5M | $6M | $5M | $8M |
| Net Income | $20M | $11M | $16M | $12M | $15M |
| Net Margin | 15.2% | 6.8% | 8.0% | 5.8% | 5.8% |
| EPS (Diluted) | $0.19 | $0.10 | $0.15 | $0.11 | $0.15 |
| EBITDA | $22M | $20M | $28M | $22M | $29M |
| Shares Outstanding | 105M | 105M | 105M | 105M | 105M |